氨力农对慢性阻塞性肺疾病患者血流动力学、血气分析、肺功能影响的研究被引量：1

下载PDF

导出

摘要目的研究氨力农对慢性阻塞性肺病(COPD)患者肺动脉高压时血流动力学、血气分析和肺功能的作用。方法测定COPD患者肺动脉高压时静脉滴注氨力农治疗前后的超声心动图、血气分析和肺功能的变化。结果用氨力农治疗后,肺动脉压(PAP)比治疗前显著下降(P<0.01)。心脏射血分数(EF)比治疗前有所增加(P>0.01)。而血气分析、血压、肺功能治疗前后无变化(P>0.05)。结论氨力农能降低COPD患者肺动脉高压,增加心脏射血分数。

作者常立军张青

机构地区山东省潍坊市人民医院药剂科山东省潍坊市人民医院呼吸科

出处《实用心脑肺血管病杂志》 2009年第12期1074-1074,共1页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

关键词慢性阻塞性肺病氨力农

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献5

1王增智,刘双.肺动脉高压的治疗进展[J].中国全科医学,2007,10(9):752-756. 被引量：9
2David B.Badesch,Steven H.Abman,Gerald Simonneau,Lewis J.Rubin,Vallerie V.McLaughlin,李井泉.美国肺动脉高压治疗指南[J].中国全科医学,2008,11(2):155-155. 被引量：7
3黄德嘉,文山,尹秋熙,朱俊,宋有城,祝善梭,孟春荣,蔡有珍,智光,陈练,马慧卿,何国祥,司良仪,刘中英,蔡力,陶剑虹,莫余波,魏宗德,田军,沈潞华,韩小茜,顾复生.米力农对慢性充血性心力衰竭血液动力学即刻效应的多中心临床研究[J].中华内科杂志,1995,34(9):599-602. 被引量：20
4慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量：5103
5Boesch C, Dubois JC, Pochmalichi G, et al. Hemodynamic study of intravenous milrinone in 26 patients with NYHA class Ⅲ or Ⅳ cardiac failure [J]. Ann Cardiol Anqeiol (Paris), 1992, 41 (9): 509.

二级参考文献40

1庞昕焱,李卫华,宋惠民,苏润毅,于建华,李跃华,毕研文,李守先.单向活瓣补片在合并重度肺动脉高压的先天性心脏病患者手术治疗中的应用[J].中华医学杂志,2004,84(11):888-890. 被引量：31
2Badesch DB,Abman SH,Aheam GS,et al.Medical therapy for pulmonary arterial hypertension:ACCP evidence-based clinical practice gidelines[J].Chest,2004,126(Suppl):35-62.
3Rich S,Kaufmann E,Levy PS.The effect of high doses of calcium-channel blockers on survival in pulmonary hypertension[J].N Engl J Med,1992,327:76-81.
4Fuster V,Steele PM,Edwards WD,et al.Primary pulmonary hypertension:natural history and the importance of thrombosis[J].Circulation,1984,70:580-587.
5Ogata M,Ohe,Shirato K,et al.Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary hypertension[J].Jpn Circ J,1993,57:63-69.
6Sitbon O,Badech DB,Channick RN,et al.Inhaled nitric oxide as a screening agent for safety identifying responders to oral calcium-channel blockers in primary pulmonary hypertension[J].Eur Respir J,1998,12:265-270.
7Sitbon O,Humbert M,Ioos V.Who benefits from long term calcium-channel bloker therapy in primary pulmonary hypertension[J] ? Am Respir Crit Care Med,2003,167:A440.
8Barst RJ,Rubin LJ,Long WA,et al.A comparison of continuous intravenous epoprostenol(prostacyclin) with conventional therapy for primary pulmonary hypertension[J].N Engl J Med,1996,334:296-302.
9Mclaughlin V,Shillington A,Rich S.Survival in primary pulmonary hypertension:the impact of epoprostenol therapy[J].Circulation,2002,106:1477-1482.
10Mclaughlin VV,Gaine SP,Barst RJ,et al.Efficacy and safety of treprostinil:an epoprostenol analog for primary pulmonary hypertension[J].J Cardiovasc Pharmacol,2003,41:293-299.